Skip to main content

Month: September 2020

진정한 고성능 이미지 캡처를 위해 설계된 신형 CLHS 카메라

캐나다 워털루, Sept. 10, 2020 (GLOBE NEWSWIRE) — Teledyne Technologies[NYSE:TDY]의 자회사이자 전 세계 머신 비전 기술의 선도기업인 Teledyne DALSA는 Teledyne e2v Lince 11.2M 흑백 센서에 기반한 신형 Falcon4-CLHS M4480과 M4400를 발표했다. 신형 Falcon4-CLHS 모델은 사용이 편리한 CLHS 인터페이스 카메라를 제공하며, 고속 데이터 전송이 필요한 산업용 이미징 응용 분야를 위해 특별하게 설계되었다. 이 모델은 부분 스캔 모델에서 초당 수천 개의 프레임을 제공하며 센서의 비닝 모드를 사용하는 경우에는 160Ke를 초과하는 매우 큰 수광면적(Full Well Capacity)을 제공할 수 있다.Teledyne DALSA의 선임 제품 관리자 매니 로메로(Manny Romero)는 “신형 Teledyne e2v Lince 11.2M CMOS 이미지 센서는 진정한 고성능 이미징이 필요한 머신 비전 응용 분야를 위한 월등한 성능과 이미지 품질을 제공합니다”라며 “최신 Falcon4-CLHS 모델이 추가됨으로써 우리는 전체 해상도에서 최대 609fps의 프레임 속도를 자랑하는 고속 11.2M 카메라에서부터 프레임 속도가 최대 16fps에 달하는 고해상도 86MP 카메라에 이르기까지 방대한 카메라 제품군을 제공하게 되어 기쁩니다”라고 설명했다.Falcon4-CLHS는 CX4 및 광섬유(AOC) 케이블 등과 같은 표준 케이블 기술을 활용하여 길이와 속도를 극대화한다. Falcon4-CLHS 카메라는 머신 비전 산업 자동화, 평면 패널 디스플레이...

Continue reading

Blood Glucose Meter Market to Expand at 9.6% CAGR and Reach USD 15,415.6 Million by 2026, Driven by Rising Uptake of Non-Invasive Meters, says Fortune Business Insights

Pune, Sept. 10, 2020 (GLOBE NEWSWIRE) — The global Blood Glucose Meter Market is likely to expand considerably in the coming years due to advent of non-invasive devices. According to a report published by Fortune Business Insights, titled “Blood Glucose Meters: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,419.0 Mn in 2018. Fortune Business Insights states that this market is likely to reach US$ 15,415.6 Mn by 2026, thereby exhibiting a CAGR of 9.6%.In this report, Fortune Business Insights has indicated that the market will grow in the near future due to the increasing demand and the subsequently rising uptake of blood glucose meters. Increasing incidence of diabetes has been a leading factor that is responsible for the surge in demand of blood glucose meters.According to the International...

Continue reading

GDS Announces Partnership on Renewable Energy Initiatives

SHANGHAI, China, Sept. 10, 2020 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS), a leading developer and operator of high-performance data centers in China, today announced that GDS and Sembcorp Industries Limited (“Sembcorp”), through their Chinese subsidiaries, signed a Memorandum of Understanding (“MoU”) to partner on renewable energy initiatives. Sembcorp, a Temasek portfolio company, has more than 700 MW of wind power assets in operation across Hebei province and Inner Mongolia autonomous region and also provides innovative water and wastewater treatment solutions in China.Under the MoU, GDS and Sembcorp will work together to develop and provide renewable energy solutions for GDS data centers wherever accessible in China. Both companies will also seek to explore other opportunities...

Continue reading

Black Diamond Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference

CAMBRIDGE, Mass. and NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s progress at the Morgan Stanley 18th Annual Global Healthcare Conference. The presentation will take place on Tuesday, September 15, 2020, at 2:45 PM ET.A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of the presentation will also be available and archived on the site for three weeks.About Black DiamondBlack Diamond Therapeutics is a precision oncology medicine...

Continue reading

Eezy Oyj – Managers Transactions

EEZY PLC — MANAGERS TRANSACTIONS — 10 SEPTEMBER 2020 AT 14.45Eezy Oyj – Managers’ Transactions____________________________________________Person subject to the notification requirementName: 9ine Consulting OyPosition: Closely associated person(X) Legal person(1):Person Discharging Managerial Responsibilities In IssuerName: Laaksola TomiPosition: Other senior managerIssuer: Eezy OyjLEI: 743700ZKOMTB7X00OW54Notification type: INITIAL NOTIFICATIONReference number: 743700ZKOMTB7X00OW54_20200910141318_6____________________________________________Transaction date: 2020-09-09Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000322326Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 8,877 Unit price: 4.44 EUR(2): Volume: 1,123 Unit price: 4.39 EURAggregated transactions(2): Volume: 10,000...

Continue reading

FuelCell Energy Reports Results for the Third Quarter of Fiscal 2020

Third Quarter Fiscal 2020 Highlights(All comparisons year-over-year unless otherwise noted)Revenues of $18.7 million compared to $22.7 millionOperating expenses decreased 16% to $7.6 million compared to $9.0 millionLoss from operations of $(10.8) million compared to $(1.1) millionNet loss increased to $(15.3) million compared to $(5.3) millionAdjusted EBITDA of $(5.6) million compared to $3.2 millionGross loss of $(3.1) million compared to gross profit of $8.0 millionBacklog of $1.33 billion, a decrease of $54.0 million, or 3.9%DANBURY, Conn., Sept. 10, 2020 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) — a global leader in fuel cell technology—with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy—today reported financial results and key business...

Continue reading

Immunodiagnostic Market to exhibit a CAGR of 4.7% and Reach USD 22,732.7 Million by 2025, Increasing Awareness for Quality Healthcare Services to Fuel Demand, says Fortune Business Insights

Pune, Sept. 10, 2020 (GLOBE NEWSWIRE) — According to the report, the global immunodiagnostic market size was valued at USD 15,777.5 Million in 2017. Moreover, the global market is forecasted to exhibit 4.7% CAGR and reach USD 22,732.7 Million by the end of 2025.  In terms of product type, the regents and consumable segment is expected to exhibit growth at a high pace during the forecast period 2018-2025.Immunodiagnostic is a new method to conduct analysis, hence its application reach is less at present. However, increasing adoption of immunodiagnostic in the diagnosis of cancer, endocrine disease, and others is likely to propel the demand in the global immunodiagnostic market.Product launch and approval for new immunodiagnostic products and services is also expected to increase the growth rate in the global market. For instance,...

Continue reading

Breast Cancer Therapeutics Market to Reach USD 38,573.5 Million at 10.2% CAGR by 2026, supported by Implementation of Favourable Reimbursement Policies, says Fortune Business Insights

Pune, Sept. 10, 2020 (GLOBE NEWSWIRE) — The increasing number of breast cancer cases all over the world is anticipated to boost the global breast cancer therapeutics market at promising rates, finds Fortune Business Insights in a new study. The study is titled, “Breast Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts”. According to the report, the global breast cancer therapeutics market, which stood at US$ 17,868.8 Mn in 2018, will reach [US$ 38,573.5 Mn] by the end of 2026. If these figures prove true, the global breast cancer therapeutics market will rise at a CAGR of 10.2% between 2018 and 2026.According to the World Health Organization, in 2018, an approximate of 627,000 women, which is tantamount to 15% of all cancer deaths worldwide, succumbed to breast cancer. The rising incidence of breast cancer...

Continue reading

Golar LNG Partners LP: Class I Director Appointment

Golar LNG Partners LP: Class I Director AppointmentGolar LNG Partners L.P. (“Golar Partners”) announces today that its Board of Directors has appointed Mr. Neil Glass as a Class I Director.  This appointment fills the Class I vacancy on the Board of Directors created by the resignation of Mr. Alf Thorkildsen in August 2020.  Mr. Glass replaces Mr. Thorkildsen and will serve out the remaining portion of Mr. Thorkildsen’s term of office, which will expire at the 2022 Annual Meeting of Limited Partners.  We welcome Neil to the Board of Directors of Golar Partners.Golar LNG Partners LPHamilton, BermudaSeptember 10, 2020Enquiries:Golar Management Limited: + 44 207 063 7900Karl Fredrik StauboStuart BuchananThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

CooperCompanies and Divisions Named One of Fortune’s Best Large Workplaces in Manufacturing and Production

SAN RAMON, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) — CooperCompanies (NYSE: COO) announced today that the company, along with its CooperVision and CooperSurgical divisions has been named one of Fortune’s Best Large Workplaces in Manufacturing and Production.“Being included on Fortune’s Best Large Workplaces in Manufacturing and Production List is a testament to our outstanding employees,” said President and CEO Albert White. “For both CooperVision and CooperSurgical, our manufacturing and production teams are the backbone of the businesses, ensuring we produce, maintain and deliver our products around the globe.  In many ways, this award highlights the team effort across the organization from the products that our R+D teams invent and study, our M+A team’s purchase, our marketing teams promote, and our sales representatives...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.